{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:05:20Z","timestamp":1743501920756},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10147-016-1016-7","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T11:36:45Z","timestamp":1468237005000},"page":"1102-1110","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent"],"prefix":"10.1007","volume":"21","author":[{"given":"Yuji","family":"Toiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Hiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadanobu","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Mohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"1016_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569\u2013578","journal-title":"Lancet"},{"key":"1016_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-med-121211-091527","volume":"64","author":"CA Gilbert","year":"2013","unstructured":"Gilbert CA, Slingerland JM (2013) Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 64:45\u201357","journal-title":"Annu Rev Med"},{"key":"1016_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579\u2013591","journal-title":"Nat Rev Cancer"},{"key":"1016_CR4","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","volume":"7","author":"M Matsuda","year":"2013","unstructured":"Matsuda M, Shimomura I (2013) Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7:e330\u2013e341","journal-title":"Obes Res Clin Pract"},{"key":"1016_CR5","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1002\/cncr.27527","volume":"118","author":"JA Sparano","year":"2012","unstructured":"Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer (Phila) 118:5937\u20135946","journal-title":"Cancer (Phila)"},{"key":"1016_CR6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.eururo.2012.08.015","volume":"62","author":"T Ho","year":"2012","unstructured":"Ho T, Gerber L, Aronson WJ et al (2012) Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol 62:910\u2013916","journal-title":"Eur Urol"},{"key":"1016_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.sla.0000150168.59592.b9","volume":"241","author":"J Leroy","year":"2005","unstructured":"Leroy J, Ananian P, Rubino F et al (2005) The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg 241:69\u201376","journal-title":"Ann Surg"},{"key":"1016_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/SLE.0b013e3181ae5442","volume":"19","author":"N Nitori","year":"2009","unstructured":"Nitori N, Hasegawa H, Ishii Y et al (2009) Impact of visceral obesity on short-term outcome after laparoscopic surgery for colorectal cancer: a single Japanese center study. Surg Laparosc Endosc Percutan Tech 19:324\u2013327","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"1016_CR9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00464-009-0829-0","volume":"24","author":"JW Park","year":"2010","unstructured":"Park JW, Lim SW, Choi HS et al (2010) The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians. Surg Endosc 24:1679\u20131685","journal-title":"Surg Endosc"},{"key":"1016_CR10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s00464-003-9259-6","volume":"18","author":"O Schwandner","year":"2004","unstructured":"Schwandner O, Farke S, Schiedeck TH et al (2004) Laparoscopic colorectal surgery in obese and nonobese patients: do differences in body mass indices lead to different outcomes? Surg Endosc 18:1452\u20131456","journal-title":"Surg Endosc"},{"key":"1016_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amjsurg.2006.04.011","volume":"192","author":"CA Lascano","year":"2006","unstructured":"Lascano CA, Kaidar-Person O, Szomstein S et al (2006) Challenges of laparoscopic colectomy in the obese patient: a review. Am J Surg 192:357\u2013365","journal-title":"Am J Surg"},{"key":"1016_CR12","first-page":"1698","volume":"51","author":"K Takeuchi","year":"2004","unstructured":"Takeuchi K, Kuwano H, Tsuzuki Y et al (2004) Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology 51:1698\u20131702","journal-title":"Hepatogastroenterology"},{"key":"1016_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2559.1997.2320843.x","volume":"31","author":"Y Sugao","year":"1997","unstructured":"Sugao Y, Yao T, Kubo C et al (1997) Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study. Histopathology (Oxf) 31:123\u2013133","journal-title":"Histopathology (Oxf)"},{"key":"1016_CR14","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1245\/s10434-012-2321-7","volume":"19","author":"JR Hyngstrom","year":"2012","unstructured":"Hyngstrom JR, Hu CY, Xing Y et al (2012) Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19:2814\u20132821","journal-title":"Ann Surg Oncol"},{"key":"1016_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jso.23845","volume":"111","author":"A Giakoustidis","year":"2015","unstructured":"Giakoustidis A, Neofytou K, Khan AZ et al (2015) Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver metastasis and thus the overall survival. J Surg Oncol 111:445\u2013450","journal-title":"J Surg Oncol"},{"key":"1016_CR16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12032-014-0855-1","volume":"31","author":"Z Chang","year":"2014","unstructured":"Chang Z, Zheng J, Ma Y et al (2014) The neutrophil-to-lymphocyte ratio as a predictor for recurrence of colorectal liver metastases following radiofrequency ablation. Med Oncol 31:855","journal-title":"Med Oncol"},{"key":"1016_CR17","first-page":"3291","volume":"33","author":"M Shibutani","year":"2013","unstructured":"Shibutani M, Maeda K, Nagahara H et al (2013) A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res 33:3291\u20133294","journal-title":"Anticancer Res"},{"key":"1016_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCO.0b013e3281a30594","volume":"10","author":"K Kalantar-Zadeh","year":"2007","unstructured":"Kalantar-Zadeh K, Horwich TB, Oreopoulos A et al (2007) Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10:433\u2013442","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1016_CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","volume":"309","author":"KM Flegal","year":"2013","unstructured":"Flegal KM, Kit BK, Orpana H et al (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309:71\u201382","journal-title":"JAMA"},{"key":"1016_CR20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jnci\/djt310","volume":"105","author":"AA Hakimi","year":"2013","unstructured":"Hakimi AA, Furberg H, Zabor EC et al (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105:1862\u20131870","journal-title":"J Natl Cancer Inst"},{"key":"1016_CR21","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.27938","volume":"119","author":"FA Sinicrope","year":"2013","unstructured":"Sinicrope FA, Foster NR, Yothers G et al (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer (Phila) 119:1528\u20131536","journal-title":"Cancer (Phila)"},{"key":"1016_CR22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/carcin\/bgs123","volume":"33","author":"ZG Fridlender","year":"2012","unstructured":"Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis (Oxf) 33:949\u2013955","journal-title":"Carcinogenesis (Oxf)"},{"key":"1016_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C et al (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298\u2013306","journal-title":"Nat Rev Cancer"},{"key":"1016_CR24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/ejso.2000.0993","volume":"26","author":"A Wein","year":"2000","unstructured":"Wein A, Hahn EG, Merkel S et al (2000) Adjuvant chemotherapy for stage II (Dukes\u2019 B) colon cancer: too early for routine use. Eur J Surg Oncol 26:730\u2013732","journal-title":"Eur J Surg Oncol"},{"key":"1016_CR25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0959-8049(95)00258-K","volume":"31A","author":"DG Haller","year":"1995","unstructured":"Haller DG (1995) An overview of adjuvant therapy for colorectal cancer. Eur J Cancer 31A:1255\u20131263","journal-title":"Eur J Cancer"},{"key":"1016_CR26","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","volume":"22","author":"AB Benson 3rd","year":"2004","unstructured":"Benson AB 3rd, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408\u20133419","journal-title":"J Clin Oncol"},{"key":"1016_CR27","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A et al (2012) ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23:2479\u20132516","journal-title":"Ann Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1016-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1016-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1016-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T19:22:35Z","timestamp":1600888955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1016-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1016-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]}}}